Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects

Abstract

Maternal use of SSRIs during early pregnancy was not associated with significantly increased risks of congenital heart defects or of most other categories of birth defects. Associations were observed between SSRI use and three types of birth defects, but the absolute risks were small, and these observations require confirmation by other studies.